INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (102279, 362, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'NCBI', 1768159683, 1768159683, NULL, NULL, NULL, NULL, NULL, NULL, NULL);